<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151327">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01875289</url>
  </required_header>
  <id_info>
    <org_study_id>VOB-Studie EK 25-387 ex 12/13</org_study_id>
    <nct_id>NCT01875289</nct_id>
  </id_info>
  <brief_title>Efficacy of a Modified Obturator Nerve Block Technique</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <authority>Austria: Federal Office for Safety in Health Care</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy of a modified obturator nerve block technique by using only a single morphological
      landmark, a double-blinded randomised pilot study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Adductor strengths</measure>
    <time_frame>pre operative, 30 minutes before start surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Adductor muscle strength is measured with a sphygmomanometer. Patients are instructed to squeeze a blod pressure cuff, already inflated to 40 mm Hg, between their extended knees. The maximal sustained pressure is taken as the baseline adductor strength.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Hip Surgery</condition>
  <condition>Knee Surgery</condition>
  <arm_group>
    <arm_group_label>Ropivacain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local anaesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NaCl 0.9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>obturator nerve block</intervention_name>
    <arm_group_label>Ropivacain</arm_group_label>
    <arm_group_label>NaCl 0.9%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists 1-3, older than 18 y, cooperative patient

        Exclusion Criteria:

          -  infection, neuromuscular deficits of the lower extremities,pregnancy, neurologic
             disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Feigl GC, Ulz H, Pixner T, Dolcet C, Likar R, Sandner-Kiesling A. Anatomical investigation of a new vertical obturator nerve block technique. Ann Anat. 2013 Jan;195(1):82-7. doi: 10.1016/j.aanat.2012.05.008. Epub 2012 Aug 10.</citation>
    <PMID>22951254</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 20, 2014</lastchanged_date>
  <firstreceived_date>June 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Graz</investigator_affiliation>
    <investigator_full_name>Andreas Sandner-Kiesling , MD</investigator_full_name>
    <investigator_title>Prof. Dr. med. univ.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
